Activation of cellular and heterologous promoters by the human herpesvirus 8 replication and transcription activator

Virology

Volumn 301, Issue 2, 2002, Pages 293-304

  Roan, Florence ^a   Inoue, Naoki ^a   Offermann, Margaret K ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

Cellular promoters; Human herpesvirus 8; Kaposi's sarcoma herpesvirus; Lytic reactivation; NF B; ORF 50; Rta; Transcription

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; PROTEIN; PROTEIN RTA; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN HERPESVIRUS 8; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; TRANSACTIVATION; TRANSCRIPTION INITIATION; VIRUS REACTIVATION; VIRUS REPLICATION;

HERPESVIRIDAE; HUMAN HERPESVIRUS 8;

EID: 0036398416     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2002.1582     Document Type: Article

References (54)

1. Adamson, A. L., Darr, D., Holley-Guthrie, E., Johnson, R. A., Mauser, A., Swenson, J., and Kenney, S. (2000). Epstein-Barr virus immediate-early proteins BZLF1 and BRLF1 activate the ATF2 transcription factor by increasing the levels of phosphorylated p38 and c-Jun N-terminal kinases. J. Virol. 74, 1224-1233.
2. Akira, S., H., Isshiki, H., Nakajima, T., Kinoshita, S., Nishio, Y., Natsuka, S., and Kishimoto, T. (1992). Regulation of expression of the interleukin 6 gene: Structure and function of the transcription factor NF-IL6. Ciba Found. Symp. 167, 47-62.
3. Akira, S., and Kishimoto, T. (1997). NF-IL6 and NF-kappa B in cytokine gene regulation. Adv. Immunol. 65, 1-46.
4. Aoki, Y., Tosato, G., Fonville, T. W., and Pittaluga, S. (2001). Serum viral interleukin-6 in AIDS-related multicentric Castleman disease. Blood 97, 2526-2527.
5. Chen, J., Ueda, K., Sakakibara, S., Okuno, T., and Yamanishi, K. (2000). Transcriptional regulation of the Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor gene. J. Virol. 74, 8623-8634.
6. Dendorfer, U., Oettgen, P., and Libermann, T. A. (1994). Multiple regulatory elements in the interleukin-6 gene mediate induction by prostaglandins, cyclic AMP, and lipopolysaccharide. Mol. Cell. Biol. 14, 4443-4454.
7. Dourado, I., Martinez-Maza, O., Kishimoto, T., Suzuki, H., and Detels, R. (1997). Interleukin 6 and AIDS-associated Kaposi's sarcoma: A nested case control study within the Multicenter AIDS Cohort Study. AIDS Res. Hum. Retroviruses 13, 781-788.
8. Drexler, H. G., Meyer, C., Gaidano, G., and Carbone, A. (1999). Constitutive cytokine production by primary effusion (body cavity-based) lymphoma-derived cell lines. Leukemia 13, 634-640.
9. Dupin, N., Fisher, C., Kellam, P., Ariad, S., Tulliez, M., Franck, N., van Marck, E., Salmon, D., Gorin, I., Escande, J. P., Weiss, R. A., Alitalo, K., and Boshoff, C. (1999). Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma. Proc. Natl. Acad. Sci. USA 96, 4546-4551.
10. Faggioli, L., Merola, M., Hiscott, J., Furia, A., Monese, R., Tovey, M., and Palmieri, M. (1997). Molecular mechanisms regulating induction of interleukin-6 gene transcription by interferon-gamma. Eur. J. Immunol. 27, 3022-3030.
11. Fan, C. M., and Maniatis, T. (1989). Two different virus-inducible elements are required for human beta-interferon gene regulation. EMBO J. 8, 101-110.
12. Foussat, A., Wijdenes, J., Bouchet, L., Gaidano, G., Neipel, F., Balabanian, K., Galanaud, P., Couderc, J., and Emilie, D. (1999). Human interleukin-6 is in vivo an autocrine growth factor for human herpesvirus-8-infected malignant B lymphocytes. Eur. Cytokine Netw. 10, 501-508.
13. Ghosh, S., May, M. J., and Kopp, E. B. (1998). NF-kappa B and Rel proteins: Evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16, 225-260.
14. Gradoville, L., Gerlach, J., Grogan, E., Shedd, D., Nikiforow, S., Metroka, C., and Miller, G. (2000). Kaposi's sarcoma-associated herpesvirus open reading frame 50/Rta protein activates the entire viral lytic cycle in the HH-B2 primary effusion lymphoma cell line. J. Virol. 74, 6207-6212.
15. Gruffat, H., and Sergeant, A. (1994). Characterization of the DNA-binding site repertoire for the Epstein-Barr virus transcription factor R. Nucleic Acids Res. 22, 1172-1178.
16. Gwack, Y., Byun, H., Hwang, S., Lim, C., and Choe, J. (2001a). CREB-binding protein and histone deacetylase regulate the transcriptional activity of Kaposi's sarcoma-associated herpesvirus open reading frame 50. J. Virol. 75, 1909-1917.
17. Gwack, Y., Hwang, S., Byun, H., Lim, C., Kim, J. W., Choi, E. J., and Choe, J. (2001b). Kaposi's sarcoma-associated herpesvirus open reading frame 50 represses p53-induced transcriptional activity and apoptosis. J. Virol. 75, 6245-6248.
18. Gwack, Y., Hwang, S., Lim, C., Won, Y. S., Lee, C. H., and Choe, J. (2002). Kaposi's sarcoma-associated herpesvirus open reading frame 50 stimulates the transcriptional activity of STAT3. J. Biol. Chem. 277, 6438-6442.
19. Harcourt, J., and Offermann, M. K. (2001). Multiple signaling cascades are differentially involved in gene induction by double stranded RNA in interferon-α-primed cells. Eur. J. Biochem. 268, 1373-1381.
20. Harcourt, J. L., and Offermann, M. K. (2000). Interferon-alpha synergistically enhances induction of interleukin-6 by double stranded RNA in HeLa cells. Eur. J. Biochem. 267, 2768-2777.
21. Hottiger, M. O., and Nabel, G. J. (2000). Viral replication and the coactivators p300 and CBP. Trends Microbiol. 8, 560-565.
22. Hu, H. M., Tian, Q., Baer, M., Spooner, C. J., Williams, S. C., Johnson, P. F., and Schwartz, R. C. (2000). The C/EBP bZIP domain can mediate lipopolysaccharide induction of the proinflammatory cytokines interleukin-6 and monocyte chemoattractant protein-1. J. Biol. Chem. 275, 16373-16381.
23. Judde, J. G., Lacoste, V., Briere, J., Kassa-Kelembho, E., Clyti, E., Couppie, P., Buchrieser, C., Tulliez, M., Morvan, J., and Gessain, A. (2000). Monoclonality or oligoclonality of human herpesvirus 8 terminal repeat sequences in Kaposi's sarcoma and other diseases. J. Natl. Cancer Inst. 92, 729-736.
24. Kamei, Y., Xu, L., Heinzel, T., Torchia, J., Kurokawa, R., Gloss, B., Lin, S. C., Heyman, R. A., Rose, D. W., Glass, C. K., and Rosenfeld, M. G. (1996). A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85, 403-414.
25. Kannabiran, C., Zeng, X., and Vales, L. D. (1997). The mammalian transcriptional repressor RBP (CBF1) regulates interleukin-6 gene expression. Mol. Cell. Biol. 17, 1-9.
26. Keller, A. D., and Maniatis, T. (1988). Identification of an inducible factor that binds to a positive regulatory element of the human beta-interferon gene. Proc. Natl. Acad. Sci. USA 85, 3309-3313.
27. Kingston, R., and Sheen, J. (1997). Phase-extraction assay for CAT activity. In "Current Protocols in Molecular Biology" (F. M. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, G. J. Seidman, J. A. Smith, and K. Struhl, Eds.), Wiley, New York.
28. Kunsch, C., Ruben, S. M., and Rosen, C. A. (1992). Selection of optimal kappa B/Rel DNA-binding motifs: Interaction of both subunits of NF-kappa B with DNA is required for transcriptional activation. Mol. Cell. Biol. 12, 4412-4421.
29. Lukac, D. M., Garibyan, L., Kirshner, J. R., Palmeri, D., and Ganem, D. (2001). DNA binding by Kaposi's sarcoma-associated herpesvirus lytic switch protein is necessary for transcriptional activation of two viral delayed early promoters. J. Virol. 75, 6786-6799.
30. Lukac, D. M., Kirshner, J. R., and Ganem, D. (1999). Transcriptional activation by the product of open reading frame 50 of Kaposi's sarcoma-associated herpesvirus is required for lytic viral reactivation in B cells. J. Virol. 73, 9348-9361.
31. Lukac, D. M., Renne, R., Kirshner, J. R., and Ganem, D. (1998). Reactivation of Kaposi's sarcoma-associated herpesvirus infection from latency by expression of the ORF 50 transactivator, a homolog of the EBV R protein. Virology 252, 304-312.
32. Miles, S. A., Rezai, A. R., Salazar-Gonzalez, J. F., Vander Meyden, M., Stevens, R. H., Logan, D. M., Mitsuyasu, R. T., Taga, T., Hirano, T., Kishimoto, T., et al. (1990). AIDS Kaposi sarcoma-derived cells produce and respond to interleukin 6. Proc. Natl. Acad. Sci. USA 87, 4068-4072.
33. Oksenhendler, E., Carcelain, G., Aoki, Y., Boulanger, E., Maillard, A., Clauvel, J. P., and Agbalika, F. (2000). High levels of human herpes-virus 8 viral load, human interleukin-6, interleukin-10, and C reactive protein correlate with exacerbation of multicentric castleman disease in HIV-infected patients. Blood 96, 2069-2073.
34. Oxholm, A., Oxholm, P., Permin, H., and Bendtzen, K. (1989). Epidermal tumour necrosis factor alpha and interleukin 6-like activities in AIDS-related Kaposi's sarcoma. An immunohistological study. APMIS 97, 533-538.
35. Palmieri, M., Sasso, M. P., Monese, R., Merola, M., Faggioli, L., Tovey, M., and Furia, A. (1999). Interaction of the nuclear protein CBF1 with the kappaB site of the IL-6 gene promoter. Nucleic Acids Res. 27, 2785-2791.
36. Plaisance, S., Vanden Berghe, W., Boone, E., Fiers, W., and Haegeman, G. (1997). Recombination signal sequence binding protein Jkappa is constitutively bound to the NF-kappaB site of the interleukin-6 promoter and acts as a negative regulatory factor. Mol. Cell. Biol. 17, 3733-3743.
37. Ray, A., LaForge, K. S., and Sehgal, P. B. (1990). On the mechanism for efficient repression of the interleukin-6 promoter by glucocorticoids: Enhancer, TATA box, and RNA start site (Inr motif) occlusion. Mol. Cell. Biol. 10, 5736-5746.
38. Ray, A., Sassone-Corsi, P., and Sehgal, P. B. (1989). A multiple cytokine-and second messenger-responsive element in the enhancer of the human interleukin-6 gene: Similarities with c-fos gene regulation. Mol. Cell. Biol. 9, 5537-5547.
39. Roizman, B. (1996). Herpesviridae. In "Field's Virology" (B. M. Fields, D. M. Knipe, P. M. Howley, et al., Eds.), Vol. 2, 3rd ed., pp. 2221-2230. 2 vols. Lippincott-Raven, Philadelphia.
40. Ruben, S. M., Narayanan, R., Klement, J. F., Chen, C. H., and Rosen, C. A. (1992). Functional characterization of the NF-kappa B p65 transcriptional activator and an alternatively spliced derivative. Mol. Cell. Biol. 12, 444-454.
41. Russo, J. J., Bohenzky, R. A., Chien, M. C., Chen, J., Yan, M., Maddalena, D., Parry, J. P., Peruzzi, D., Edelman, I. S., Chang, Y., and Moore, P. S. (1996). Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc. Natl. Acad. Sci. USA 93, 14862-14867.
42. Sakakibara, S., Ueda, K., Chen, J., Okuno, T., and Yamanishi, K. (2001). Octamer-binding sequence is a key element for the autoregulation of Kaposi's sarcoma-associated herpesvirus orf50/lyta gene expression. J. Virol. 75, 6894-6900.
43. Sanceau, J., Kaisho, T., Hirano, T., and Wietzerbin, J. (1995). Triggering of the human interleukin-6 gene by interferon-gamma and tumor necrosis factor-alpha in monocytic cells involves cooperation between interferon regulatory factor-1, NF kappa B, and Sp1 transcription factors. J. Biol. Chem. 270, 27920-27931.
44. Schulz, T. F. (2000). Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8): Epidemiology and pathogenesis. J. Antimicrob. Chemother. 45(Suppl. T3), 15-27.
45. Sheppard, K. A., Rose, D. W., Haque, Z. K., Kurokawa, R., McInerney, E., Westin, S., Thanos, D., Rosenfeld, M. G., Glass, C. K., and Collins, T. (1999). Transcriptional activation by NF-kappaB requires multiple coactivators. Mol. Cell. Biol. 19, 6367-6378.
46. Song, M. J., Brown, H. J., Wu, T. T., and Sun, R. (2001). Transcription activation of polyadenylated nuclear rna by rta in human herpesvirus 8/Kaposi's sarcoma-associated herpesvirus. J. Virol. 75, 3129-3140.
47. Sturzl, M., Blasig, C., Schreier, A., Neipel, F., Hohenadl, C., Cornali, E., Ascherl, G., Esser, S., Brockmeyer, N. H., Ekman, M., Kaaya, E. E., Tschachler, E., and Biberfeld, P. (1997). Expression of HHV-8 latency-associated T0.7 RNA in spindle cells and endothelial cells of AIDS-associated, classical and African Kaposi's sarcoma. Int. J. Cancer 72, 68-71.
48. Sun, R., Lin, S. F., Gradoville, L., Yuan, Y., Zhu, F., and Miller, G. (1998). A viral gene that activates lytic cycle expression of Kaposi's sarcoma-associated herpesvirus. Proc. Natl. Acad. Sci. USA 95, 10866-10871.
49. Swenson, J. J., Mauser, A. E., Kaufmann, W. K., and Kenney, S. C. (1999). The Epstein-Barr virus protein BRLF1 activates S phase entry through E2F1 induction. J. Virol. 73, 6540-6550.
50. Takeshita, F., Ishii, K. J., Ueda, A., Ishigatsubo, Y., and Klinman, D. M. (2000). Positive and negative regulatory elements contribute to CpG oligonucleotide-mediated regulation of human IL-6 gene expression. Eur. J. Immunol. 30, 108-116.
51. Vanden Berghe, W., Vermeulen, L., De Wilde, G., De Bosscher, K., Boone, E., and Haegeman, G. (2000). Signal transduction by tumor necrosis factor and gene regulation of the inflammatory cytokine interleukin-6. Biochem. Pharmacol. 60, 1185-1195.
52. Wagner, E. K. (1991). Herpesvirus transcription; general aspects. In "Herpesvirus Transcription and Its Regulation" (E. K. Wagner, Ed.), pp.1-15. CRC Press, Boca Raton, FL.
53. Wang, S., Liu, S., Wu, M., Geng, Y., and Wood, C. (2001). Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8 ORF50 gene product contains a potent C-terminal activation domain which activates gene expression via a specific target sequence. Arch. Virol. 146, 1415-1426.
54. Zacny, V. L., Wilson, J., and Pagano, J. S. (1998). The Epstein-Barr virus immediate-early gene product, BRLF1, interacts with the retinoblastoma protein during the viral lytic cycle. J. Virol. 72, 8043-8051.